Can a Wyoming resident get peptides by telehealth?
Wyoming Statutes section 33-26-102(a)(xxix) defines telemedicine as the practice of medicine by electronic communication or other means from a physician in a location to a patient in another location, with or without an intervening health care provider, and section 33-26-202(b)(xix) authorizes the Wyoming Board of Medicine to adopt telemedicine rules. The Board's rules treat telemedicine into Wyoming as requiring a Wyoming license unless an exemption applies. Board of Medicine rules chapter 1, section 7 (Exemption from licensure) carves out narrow exceptions: section 7(a) lets an out-of-state physician brought in for consultation by a Wyoming-licensed physician, in person or through telemedicine, practice for up to 12 days in any 52-week period; and section 7(e) lets an out-of-state physician or physician assistant who first saw a Wyoming resident in person in a state where they are licensed continue that care by telehealth for up to six months, after which another in-person visit is required, with new conditions referred to a Wyoming-licensed provider. Section 33-26-402(a)(xxxiii) treats initially prescribing controlled substances over the internet absent a documented physician-patient relationship as grounds for discipline; GLP-1 medicines and the peptides in this database are not controlled. The statute and the Board's rules define the physician-patient relationship without naming any required technology, and neither mentions store-and-forward, real-time visits, or questionnaires. This record classifies asynchronous prescribing as unresolved because the law is silent: no Wyoming statute or Board of Medicine rule says whether an asynchronous encounter alone can support a new prescription. [3] [4] [7]
How does the Wyoming pharmacy board treat compounding?
| Board | Wyoming State Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Wyoming State Board of Pharmacy licenses pharmacies under the Wyoming Pharmacy Act (Wyoming Statutes title 33, chapter 24) and the Board's rules. Section 33-24-152 requires a nonresident pharmacy that dispenses to Wyoming patients to hold a Wyoming license, stay licensed in its home state, keep readily retrievable records of controlled substances and dangerous drugs dispensed to Wyoming patients, comply with the Wyoming generic substitution requirements, and offer a toll-free pharmacist line at least six days and 40 hours a week; the Board may deny, suspend, or revoke the license and assess penalties of up to $2,000 per violation. Compounding is governed by chapter 22 (Compounding) of the Board's Pharmacy Act rules, effective August 19, 2025, which replaced the repealed chapter 13 (non-sterile compounding) and chapter 17 (sterile compounding). Chapter 22 applies to all licensees and adopts by reference USP-NF general chapters 795 (non-sterile), 797 (sterile), 800 (hazardous drugs), and 825 (radiopharmaceuticals) as minimum standards; a 2026 amendment proposed by the Board only fixes the reference date to USP-NF 2024, Issue 1 (official May 1, 2024). Chapter 22 does not set a state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [5] [6] [7] [8] [9]
Can you get compounded GLP-1s in Wyoming?
Because rural Wyoming patients often rely on mail order, the practical check is that the shipping pharmacy holds a Wyoming nonresident pharmacy license under section 33-24-152. [1] [8] [12]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Wyoming?
Access options
Prescriber licensed in Wyoming, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Wyoming. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one.
Pharmacy licensed or registered with the Wyoming State Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Wyoming
What you'll actually find in Wyoming, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [14] [15] [16]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [17]
What Wyoming has done
PeptideAgent has not found a board or legislative action on peptides in Wyoming.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [19] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [20] [21] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Wyoming. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [3] [4] [7] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Wyoming State Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [18]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [17]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [10] [22] [23]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [18] [24] [25]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [16] [25] [26]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [17] [27] [28] [29] [30] [31]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [17]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [18]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [16]
- Pharmacy: Is this made for me on a prescription written in my name? [26]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [16] [25]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [16]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Wyoming?
The Wyoming Pharmacy Act (title 33, chapter 24) limits dispensing of prescription drugs to licensed pharmacies, including licensed nonresident pharmacies, so a seller shipping "research use only" injectable peptides to Wyoming consumers is outside the licensed channel. [7] [13]
Peptide-specific notes for Wyoming
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in Wyoming through telemedicine?
Yes. Wyoming treats telemedicine as the practice of medicine under section 33-26-102, so a Wyoming-licensed physician can evaluate you and prescribe remotely, subject to Board of Medicine rules. Wyoming law does not settle whether the visit must be live: no statute or Board of Medicine rule mentions store-and-forward, real-time visits, or questionnaires. [3] [4] [7]
Does an out-of-state telehealth doctor need a Wyoming license?
Generally yes. The Board of Medicine's rules treat telemedicine into Wyoming as requiring a Wyoming license unless an exemption applies. The rules allow narrow exceptions, such as consultation with a Wyoming-licensed physician and limited continuation of an existing relationship, but a new GLP-1 patient should expect a Wyoming-licensed prescriber. [3] [4] [7]
What does an out-of-state pharmacy need to ship compounded peptides to Wyoming?
A Wyoming nonresident pharmacy license under section 33-24-152. The pharmacy must remain licensed in its home state, keep records of drugs dispensed to Wyoming patients, and provide a toll-free line to a pharmacist at least 40 hours a week. The Board can fine violations up to $2,000 each. [1] [8]
Can a Wyoming pharmacy compound peptides that are not on the FDA bulks list?
Generally no. Wyoming has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [2] [9] [10]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Wyoming State Board of Pharmacy
- [2]Wyoming State Board of Pharmacy: laws and rules
- [3]Wyoming Board of Medicine
- [4]Wyoming Board of Medicine: rules and regulations (chapter 1, section 7, Exemption from licensure)
- [5]Wyoming State Board of Pharmacy rules, chapter 22, Compounding (effective August 19, 2025)
- [6]Wyoming State Board of Pharmacy: chapter 22 Compounding, notice and text of proposed 2026 revisions
- [7]Wyoming Statutes title 33, Professions and occupations (including 33-26-102(a)(xxix) telemedicine definition, 33-26-202 board powers, and chapter 24 Pharmacy Act)
- [8]Wyoming Statutes section 33-24-152, Nonresident pharmacy registration and licensure
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 4). Are peptides legal in Wyoming?. https://peptideagent.ai/legal/wyoming- HTML link
<a href="https://peptideagent.ai/legal/wyoming">Are peptides legal in Wyoming?</a>, PeptideAgent, updated October 4, 2026.